Procaps Group, S.A Operating Income 2020-2023 | PROCF
Procaps Group, S.A operating income from 2020 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Procaps Group, S.A Annual Operating Income
(Millions of US $) |
| 2022 |
$40 |
| 2021 |
$70 |
| 2020 |
$63 |
| 2020 |
$-1 |
| 2019 |
$37 |
| 2019 |
$-0 |
| 2018 |
$-0 |
Procaps Group, S.A Quarterly Operating Income
(Millions of US $) |
| 2023-09-30 |
$13 |
| 2023-06-30 |
$15 |
| 2023-03-31 |
$3 |
| 2022-12-31 |
$2 |
| 2022-09-30 |
$17 |
| 2022-06-30 |
$18 |
| 2022-03-31 |
$2 |
| 2021-12-31 |
$36 |
| 2021-09-30 |
$18 |
| 2021-06-30 |
$16 |
| 2021-03-31 |
$-0 |
| 2020-12-31 |
$252 |
| 2020-09-30 |
$14 |
| 2020-06-30 |
$-0 |
| 2020-03-31 |
$-0 |
| 2019-12-31 |
$-0 |
| 2019-09-30 |
|
| 2019-06-30 |
|
| 2019-03-31 |
$-0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.125B |
$0.410B |
|
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|
